HighLife raises EUR 80 million in funding round
HighLife raised more than USD 90 million (EUR 80 million) in a private financing round to fund a US pivotal study. Proceeds also target faster commercial expansion in Europe following CE Mark clearance for its transcatheter mitral valve replacement system. Round was co-led by Andera Partners, Sofinnova Partners, Supern